Merck (LTS:0QAH) FFO


LTS:0QAH Merck & Co Inc LTS:0QAH
85 GF Score
Price $123.22
GF Value $118.35
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Merck FFO?

FFO (Funds from operations) only applies to REITs.

LTS:0QAH
85GF Score
Merck & Co Inc LTS:0QAH
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Merck (LTS:0QAH) Overvalued in 2026?

Based on GuruFocus' analysis, Merck stock appears to be overvalued. The current stock price of $123.22 is trading 4.1% above its estimated GF Value™ of $118.35. GuruFocus considers Merck to be Fairly Valued.

Key valuation signals for LTS:0QAH:

  • FFO:
  • GF Value™: $118.35 vs. price of $123.22 (4.1% above fair value)
  • GF Score™: 85/100 with 8 warning signs

No single metric tells the full story. See the LTS:0QAH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Merck Business Description

Address 126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
85GF Score

Get the complete analysis for LTS:0QAH

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$123.22
Price
$118.35
GF Value